RemSleep Holdings (RMSL) Operating Expenses (2010 - 2025)
RemSleep Holdings recorded quarterly Operating Expenses of $213000.0 in Q4 2025, down 90.7% quarter-over-quarter from $2.3 million in Q3 2025, and up 40.37% year-over-year from $151746.0 in Q4 2024.
RemSleep Holdings' Operating Expenses history runs 16 years deep, the most recent figure standing at $213000.0 for Q4 2025.
- In Q4 2025, Operating Expenses rose 40.37% year-over-year to $213000.0; the TTM figure through Dec 2025 stood at $2.8 million (up 241.53% YoY), while the FY2025 annual figure was $2.8 million, up 241.53% from the prior year.
- Operating Expenses came in at $213000.0 for Q4 2025 at RemSleep Holdings, down from $2.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $2.3 million in Q3 2025 to a low of -$649543.0 in Q4 2022.
- A 5-year average of $251679.0 and a median of $161532.0 in 2022 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses plunged 667.41% in 2022 and jumped 3089.59% in 2024, its largest moves.
- RemSleep Holdings' Operating Expenses stood at $114475.0 in 2021, then slumped by 667.41% to -$649543.0 in 2022, then soared by 142.88% to $278525.0 in 2023, then sank by 45.52% to $151746.0 in 2024, then soared by 40.37% to $213000.0 in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $213000.0, $2.3 million, and $136776.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 822.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -668.50 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 495.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 380.30 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 | 213,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 213,000.00 |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 136,776.00 |
| Mar 31, 2025 | 131,315.00 |
| Dec 31, 2024 | 151,746.00 |
| Sep 30, 2024 | 172,815.00 |
| Jun 30, 2024 | 318,519.00 |
| Mar 31, 2024 | 168,506.00 |
| Dec 31, 2023 | 278,525.00 |
| Sep 30, 2023 | 273,334.00 |
| Jun 30, 2023 | 229,989.00 |
| Mar 31, 2023 | 5,283.00 |
| Dec 31, 2022 | -649,543.00 |
| Sep 30, 2022 | 357,822.00 |
| Jun 30, 2022 | 374,553.00 |
| Mar 31, 2022 | 154,558.00 |
| Dec 31, 2021 | 114,475.00 |
| Sep 30, 2021 | 81,863.00 |
| Jun 30, 2021 | 135,086.00 |
| Mar 31, 2021 | 94,264.00 |
| Dec 31, 2020 | 217,870.00 |
| Sep 30, 2020 | 58,107.00 |
| Jun 30, 2020 | 114,475.00 |
| Mar 31, 2020 | 79,392.00 |
| Dec 31, 2019 | 90,296.00 |
| Sep 30, 2019 | 112,440.00 |
| Jun 30, 2019 | 2.09 Mn |
| Mar 31, 2019 | 49,869.00 |
| Dec 31, 2018 | -400,158.00 |
| Sep 30, 2018 | 242,939.00 |
| Jun 30, 2018 | 306,990.00 |
| Mar 31, 2018 | 144,610.00 |
| Dec 31, 2017 | 85,087.00 |
| Sep 30, 2017 | 109,418.00 |
| Jun 30, 2017 | 284,357.00 |
| Mar 31, 2017 | 172,603.00 |
| Dec 31, 2016 | 167,305.00 |
| Sep 30, 2016 | 241.00 |
| Jun 30, 2016 | 3,230.00 |
| Mar 31, 2016 | 26,260.00 |
| Dec 31, 2015 | 13,367.00 |
| Sep 30, 2015 | 230.00 |
| Jun 30, 2015 | 38,613.00 |
| Mar 31, 2015 | 34,163.00 |
| Dec 31, 2014 | 82,831.00 |
| Dec 31, 2013 | 261,545.00 |
| Sep 30, 2013 | 202,069.00 |
| Jun 30, 2013 | 808,285.00 |
| Mar 31, 2013 | 206,286.00 |
| Dec 31, 2012 | 261,746.00 |
| Sep 30, 2012 | 470,642.00 |
| Jun 30, 2012 | 654,141.00 |
| Mar 31, 2012 | 17,254.00 |
| Dec 31, 2011 | 22,661.00 |
| Jun 30, 2011 | 69,188.00 |
| Mar 31, 2011 | 19,061.00 |
| Dec 31, 2010 | 183,796.00 |
| Sep 30, 2010 | 331,561.00 |